Jeff Chaffkin
Jeff Chaffkin
earnings growth percent piece reported side spin
Pharmacia reported earnings growth of 19 percent, but the pharmaceutical side was up more than 20 percent by itself, so that's the sustainable long-term piece when they spin off agriculture.
coming cost entire focusing issue itself keeps major obviously pricing spending
It's obviously part of the entire issue of focusing on drug spending and cost and pricing which keeps coming up, but this issue itself is not a major issue.
good surprises trend
There were no surprises from AHP. I think that's a good trend in general.
cost hard losing offset product simply
I really think what you've had here is that they've all had the same issue, losing product patents. It's hard to simply offset that with cost cutting, but it's nothing systemic in the company.